Yilong Ma

813 citations
26 papers · 435 indexed · h-index 11
Topics
Hepatocellular Carcinoma Treatment and Prognosis (9 papers)Liver Disease Diagnosis and Treatment (6 papers)Cancer Mechanisms and Therapy (3 papers)

In The Last Decade

Yilong Ma

24 papers receiving 423 citations

Peers

Yilong Ma
Comparison fields: 5 of 81
  • Hepatology 137
  • Sensory Systems 121
  • Neurology 101
  • Epidemiology 62
  • Pathology and Forensic Medicine 55
Replace Dongdong Ren with:
Dongdong Ren China
Toshio Ishibashi Japan
Ho Joong Kim South Korea
Zian Xiao China
Yu Su China
Aaron M. Dingle United States
Tsutomu Kawano Japan
Elliot E. Hui United States
Yu‐Chun Chen Taiwan
Yilong Ma relative to Dongdong Ren China Dongdong Ren's profile →
Citations per field
00.5×10×20×30×40×45.7×
Dongdong Ren · 1×
Citations per year

Countries citing papers authored by Yilong Ma

Since Specialization
Citations

This map shows the geographic impact of Yilong Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yilong Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yilong Ma more than expected).

Fields of papers citing papers by Yilong Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yilong Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yilong Ma. The network helps show where Yilong Ma may publish in the future.

Co-authorship network of co-authors of Yilong Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Yilong Ma. A scholar is included among the top collaborators of Yilong Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yilong Ma. Yilong Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 8
2 3
3 2
4 22
5 1
6 11
7 5
8 23
9 1
10 22
11 10
12 4
13 7
14 54
15 21
16 3
17
TACE combined with percutaneous microwave ablation in treatment of large primary hepatocellular carcinoma
0
18 35
19
Clinical Study of Octreotide for Advanced Hepatocellular carcinoma
4
20 149

About Yilong Ma

Yilong Ma is a scholar working on Hepatology, Electronic, Optical and Magnetic Materials and Sensory Systems, having authored 26 papers that have together received 435 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (9 papers), Liver Disease Diagnosis and Treatment (6 papers) and Cancer Mechanisms and Therapy (3 papers). The work is most often cited by research in Sensory Systems (121 citations), Hepatology (137 citations) and Neurology (101 citations). Yilong Ma has collaborated with scholars based in China, Hong Kong and Saudi Arabia. Frequent co-authors include Alec N. Salt, Chang Zhao, Jiye Zhu, Le‐Qun Li, Bang‐De Xiang, Chao Zhao, W. Y. Lau, Jian‐Hong Zhong, Xiang Xiao and Chao Luo. Their work appears in journals such as PLoS ONE, Inorganic Chemistry and Molecules.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026